KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Cash from Financing Activities: 2013-2025

Historic Cash from Financing Activities for CareDx (CDNA) over the last 12 years, with Sep 2025 value amounting to -$26.5 million.

  • CareDx's Cash from Financing Activities fell 1962.03% to -$26.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$81.8 million, marking a year-over-year decrease of 159.14%. This contributed to the annual value of -$5.6 million for FY2024, which is 81.06% up from last year.
  • According to the latest figures from Q3 2025, CareDx's Cash from Financing Activities is -$26.5 million, which was up 50.79% from -$53.8 million recorded in Q2 2025.
  • In the past 5 years, CareDx's Cash from Financing Activities ranged from a high of $189.2 million in Q1 2021 and a low of -$53.8 million during Q2 2025.
  • Moreover, its 3-year median value for Cash from Financing Activities was -$1.3 million (2024), whereas its average is -$10.6 million.
  • As far as peak fluctuations go, CareDx's Cash from Financing Activities soared by 25,845.31% in 2021, and later crashed by 1,962.03% in 2025.
  • Over the past 5 years, CareDx's Cash from Financing Activities (Quarterly) stood at -$834,000 in 2021, then tumbled by 184.41% to -$2.4 million in 2022, then slumped by 1,033.09% to -$26.9 million in 2023, then soared by 96.64% to -$903,000 in 2024, then crashed by 1,962.03% to -$26.5 million in 2025.
  • Its Cash from Financing Activities stands at -$26.5 million for Q3 2025, versus -$53.8 million for Q2 2025 and -$643,000 for Q1 2025.